SCHEMBL23309587

SCHEMBL23309587

Cc1cc(C)cc(NC(=O)c2cc(F)nc(F)c2F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ P2RX1 P51575 1/20 0.44
▸ TMPRSS4 Q9NRS4 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ F12 P00748 2/20 0.43
▸ MAOA P21397 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ SCN10A Q9Y5Y9 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.41
▸ TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309621 0.87 RAB9A (0.50) MAPTKDM4EHPGDALDH1A1F12
SCHEMBL23309536 0.86 MEN1 (0.55) KDM4EHPGDL3MBTL1ALDH1A1F12
SCHEMBL23309730 0.84 KMT2A (0.47) MAPTKDM4EP2RX1ALDH1A1MAOA
SCHEMBL23309614 0.84 LCK (0.45) MAPTALDH1A1
SCHEMBL23309502 0.83 NFKB1 (0.51) MAPTKDM4EHPGDP2RX1TMPRSS4
SCHEMBL23309483 0.81 CYP1A2 (0.52) MAPTALDH1A1MAOAMAOBMEN1
SCHEMBL23309477 0.81 ATF1 (0.51) MAPTKDM4EP2RX1ALDH1A1MAOA
SCHEMBL23309546 0.81 NFKB1 (0.50) MAPTKDM4EP2RX1TMPRSS4KMT2A
SCHEMBL23309533 0.80 ALDH1A1 (0.43) MAPTTHRBALDH1A1KMT2APOLB
SCHEMBL23309490 0.80 GAA (0.51) KDM4EHPGDL3MBTL1ALDH1A1F12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL MAPT 1126/4885KDM4E 3438/4885HPGD 3625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback